Management of Vascular Risk Factors in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) [Stroke]

Conclusions Site-based risk-factor control improved significantly in the first 6 months and over the long term in CREST but was often suboptimal. Intensive medical management should be considered for future trials of carotid revascularization. Clinical Trial Registration URL: ClinicalTrials.gov. Unique identifier: NCT00004732.

http://jaha.ahajournals.org/cgi/content/short/3/6/e001180?rss=1

Source: JAHA:Journal of the American Heart Association - November 26, 2014 Category: Cardiology Authors: Meschia, J. F., Voeks, J. H., Leimgruber, P. P., Mantese, V. A., Timaran, C. H., Chiu, D., Demaerschalk, B. M., Howard, V. J., Hughes, S. E., Longbottom, M., Howard, A. G., Brott, T. G. Tags: Stroke Source Type: research